Nelson Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516K Hold
4,016
0.06% 86
2026
Q1
$483K Sell
4,016
-29
-0.7% -$3.35K 0.06% 82
2025
Q4
$426K Sell
4,045
-613
-13% -$57.5K 0.05% 88
2025
Q3
$391K Sell
4,658
-250
-5% -$20.6K 0.05% 91
2025
Q2
$389K Sell
4,908
-316
-6% -$25.1K 0.05% 88
2025
Q1
$469K Sell
5,224
-500
-9% -$46.7K 0.08% 81
2024
Q4
$569K Sell
5,724
-30,402
-84% -$3.13M 0.09% 82
2024
Q3
$4.1M Buy
36,126
+904
+3% +$107K 0.69% 37
2024
Q2
$4.36M Buy
35,222
+1,658
+5% +$214K 0.77% 32
2024
Q1
$4.43M Sell
33,564
-719
-2% -$88.6K 0.85% 33
2023
Q4
$3.74M Sell
34,283
-825
-2% -$85.6K 0.84% 34
2023
Q3
$3.61M Sell
35,108
-986
-3% -$106K 0.89% 35
2023
Q2
$4.17M Sell
36,094
-703
-2% -$79.8K 1.08% 30
2023
Q1
$3.92M Sell
36,797
-1,101
-3% -$119K 1.11% 31
2022
Q4
$4.21M Sell
37,898
-78
-0.2% -$7.97K 1.23% 32
2022
Q3
$3.27M Buy
37,976
+34,506
+994% +$3.08M 0.96% 40
2022
Q2
$316K Hold
3,470
0.09% 83
2022
Q1
$285K Hold
3,470
0.06% 92
2021
Q4
$266K Hold
3,470
0.05% 96
2021
Q3
$261K Hold
3,470
0.05% 90
2021
Q2
$270K Sell
3,470
-156
-4% -$11.6K 0.05% 91
2021
Q1
$267K Hold
3,626
0.06% 89
2020
Q4
$283K Sell
3,626
-398
-10% -$30.4K 0.06% 82
2020
Q3
$319K Sell
4,024
-262
-6% -$20.5K 0.06% 85
2020
Q2
$316K Sell
4,286
-349
-8% -$26.3K 0.07% 80
2020
Q1
$340K Hold
4,635
0.09% 75
2019
Q4
$402K Sell
4,635
-944
-17% -$77.5K 0.08% 79
2019
Q3
$448K Buy
5,579
+821
+17% +$65.8K 0.11% 70
2019
Q2
$381K Sell
4,758
-472
-9% -$36.1K 0.09% 77
2019
Q1
$415K Sell
5,230
-32
-0.6% -$2.39K 0.1% 70
2018
Q4
$384K Hold
5,262
0.11% 72
2018
Q3
$356K Buy
5,262
+640
+14% +$40.8K 0.08% 71
2018
Q2
$268K Buy
4,622
+786
+20% +$44.3K 0.07% 78
2018
Q1
$199K Sell
3,836
-510
-12% -$27.5K 0.05% 89
2017
Q4
$233K Buy
4,346
+175
+4% +$9.7K 0.07% 81
2017
Q3
$255K Hold
4,171
0.08% 76
2017
Q2
$255K Hold
4,171
0.09% 77
2017
Q1
$253K Hold
4,171
0.09% 76
2016
Q4
$234K Buy
4,171
+838
+25% +$49K 0.08% 77
2016
Q3
$198K Buy
3,333
+969
+41% +$56.7K 0.07% 80
2016
Q2
$130K Sell
2,364
-441
-16% -$23.5K 0.05% 77
2016
Q1
$142K Hold
2,805
0.05% 72
2015
Q4
$141K Buy
2,805
+524
+23% +$26.4K 0.05% 71
2015
Q3
$108K Hold
2,281
0.04% 82
2015
Q2
$124K Sell
2,281
-72
-3% -$4.04K 0.04% 85
2015
Q1
$129K Hold
2,353
0.05% 82
2014
Q4
$127K Buy
2,353
+175
+8% +$9.75K 0.05% 87
2014
Q3
$123K Sell
2,178
-358
-14% -$20.1K 0.05% 89
2014
Q2
$140K Sell
2,536
-231
-8% -$12.6K 0.06% 79
2014
Q1
$150K Buy
2,767
+199
+8% +$10.3K 0.07% 77
2013
Q4
$123K Hold
2,568
0.05% 81
2013
Q3
$117K Hold
2,568
0.06% 82
2013
Q2
$114K Buy
+2,568
New +$115K 0.06% 83

Other funds holding MRK

Nelson Capital Management's MRK Position: Q2 2026 in Review

Nelson Capital Management held its Merck (MRK) position steady in Q2 2026 at 4,016 shares worth $516K. The position accounts for 0.06% of the portfolio, ranked #86.

Nelson Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.43M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Nelson Capital Management held 4,016 shares of Merck worth $516K as of Q2 2026.
  • Nelson Capital Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.06% of Nelson Capital Management's portfolio in Q2 2026, its #86 holding.
  • Nelson Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Nelson Capital Management's Merck position peaked at $4.43M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Nelson Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.